Treatment of cystic disease with tnf-a

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/19 (2006.01) A61K 31/19 (2006.01) A61K 31/192 (2006.01) A61K 31/40 (2006.01) A61K 31/404 (2006.01) A61K 31/405 (2006.01) A61K 31/4745 (2006.01)

Patent

CA 2250403

A method for treating polycystic kidney disease in an individual in need thereof. This method includes identifying a mammal having a cystic disease and administering to the mammal a pharmacologically effective anticystic amount of TNF-alpha or an agent which stimulates TNF-alpha production in vivo. The agent is administered in a pharmacologically acceptable carrier, excipient or diluent.

L'invention concerne une méthode de traitement d'une maladie polykystique du rein chez un patient. Cette méthode consiste à identifier un mammifère atteint d'une maladie kystique et à lui administrer une quantité pharmaceutiquement efficace de TNF-alpha ou d'un agent stimulant la production in vivo de TNF-alpha, telle qu'elle agit contre ladite maladie kystique. Ledit agent est administré dans un porteur, un excipient ou un diluant pharmaceutiquement acceptables.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of cystic disease with tnf-a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of cystic disease with tnf-a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cystic disease with tnf-a will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1486610

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.